Psf1 Activators
Psf1 Activators encompass a diverse array of chemical compounds that indirectly promote the functional activity of Psf1 by modulating cellular signaling pathways that culminate in the phosphorylation and stabilization of the GINS complex, a critical component in the initiation of DNA replication. Forskolin, 8-Br-cAMP, and IBMX all serve to elevate intracellular cAMP levels, with the consequent activation of PKA. This kinase plays a pivotal role in the phosphorylation of DNA replication machinery, which is instrumental in enhancing the activity of Psf1. Similarly, caffeine and the selective PDE4 inhibitor Rolipram increase cAMP levels, further potentiating Psf1 activity via PKA signaling. These mechanisms ensure that Psf1, through phosphorylation by PKA, supports the proper assembly of the GINS complex, thereby facilitating its essential role in DNA replication.
In addition to cAMP modulators, compounds like Epigallocatechin gallate provide a broader kinase inhibitory effect, which may reduce competitive signaling and indirectly increase Psf1 activity in its pathway. The PDE5 inhibitors Sildenafil, Vardenafil, Tadalafil, and Zaprinast, along with the PDE1 inhibitor Vinpocetine and the PDE3 inhibitor Anagrelide, also elevate cAMP and cGMP levels, leading to PKA activation. Through these actions, these activators enhance Psf1 phosphorylation and activity, emphasizing the non-redundant role of Psf1 in the GINS complex for DNA replication.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly raises intracellular cAMP levels, which activates PKA. PKA phosphorylation can enhance Psf1 activity by promoting the assembly and stability of the GINS complex, which is essential for the initiation of DNA replication. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cell-permeable cAMP analog that activates PKA. Activated PKA can phosphorylate components of the DNA replication machinery, potentially enhancing the functional activity of Psf1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, leading to increased cAMP levels and subsequent PKA activation. Through PKA, Psf1's role in the DNA replication process can be enhanced. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This polyphenol inhibits several protein kinases, potentially reducing competitive signaling pathways and indirectly increasing the activity of Psf1 within its specific pathway in DNA replication. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
By inhibiting phosphodiesterases, caffeine increases cAMP levels, which can activate PKA and thereby enhance the activity of Psf1 by promoting the formation of the GINS complex. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a selective PDE4 inhibitor, raises intracellular cAMP levels, leading to PKA activation. PKA can then positively influence Psf1 activity by phosphorylation, enhancing its role in DNA replication. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil is another PDE5 inhibitor, which can indirectly enhance Psf1's role by increasing cAMP/cGMP levels and PKA activation, promoting DNA replication processes involving Psf1. | ||||||
Tadalafil | 171596-29-5 | sc-208412 | 50 mg | $180.00 | 13 | |
Tadalafil's inhibition of PDE5 leads to increased cAMP and cGMP levels, potentially enhancing Psf1 activity through the activation of PKA and its effects on DNA replication. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast, a PDE5 inhibitor, raises cGMP levels which can have a downstream effect on PKA activation, thereby enhancing the functional activity of Psf1 in DNA replication. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine inhibits PDE1, leading to increased cAMP and cGMP levels, which can indirectly activate Psf1 by PKA-dependent phosphorylation processes. | ||||||